BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/10/2022 2:26:33 PM | Browse: 238 | Download: 731
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 70492
Country China
Received
2021-08-05 00:53
Peer-Review Started
2021-08-05 00:56
To Make the First Decision
Return for Revision
2021-10-03 21:03
Revised
2021-10-09 06:55
Second Decision
2022-01-06 03:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-01-06 19:08
Articles in Press
2022-01-06 19:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-01-04 22:46
Typeset the Manuscript
2022-02-07 01:54
Publish the Manuscript Online
2022-02-10 14:26
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes
Manuscript Source Unsolicited Manuscript
All Author List Jin-Jia Chang, Xiao-Yu Wang, Wei Zhang, Cong Tan, Wei-Qi Sheng and Mi-Die Xu
ORCID
Author(s) ORCID Number
Jin-Jia Chang http://orcid.org/0000-0002-9105-8691
Xiao-Yu Wang http://orcid.org/0000-0002-7280-7327
Wei Zhang http://orcid.org/0000-0002-7622-9018
Cong Tan http://orcid.org/0000-0001-6912-4579
Wei-Qi Sheng http://orcid.org/0000-0002-8726-277X
Mi-Die Xu http://orcid.org/0000-0003-1775-6608
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China (General Program) 81972249
National Natural Science Foundation of China (General Program) 81802367
National Natural Science Foundation of China (General Program) 81802361
National Natural Science Foundation of China (General Program) 82172702
Shanghai Clinical Research Plan of SHDC SHDC2020CR4068
Shanghai Clinical Science and Technology Innovation Project of Municipal Hospital SHDC12020102
Shanghai Science and Technology Development Fund 18ZR1408000
Shanghai Science and Technology Development Fund 21ZR1414900
Shanghai Science and Technology Development Fund 19MC1911000
Clinical Research Project of Shanghai Municipal Health Committee 20194Y0348
Shanghai “Rising Stars of Medical Talents” Youth Development Program Youth Medical Talents – Specialist Program SHWSRS(2020)_087
Corresponding Author Wei-Qi Sheng, PhD, Chief Doctor, Director, Professor, Teacher, Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai 200032, China. shengweiqi2006@163.com
Key Words Gastric cancer; Molecular subtype; Energy-metabolism-related genes; Prognosis factor; Roadmap
Core Tip On the basis of 86 EMRGs that were significantly associated to patients’ progression-free survival (PFS), we propose a molecular classification dividing stomach adenocarcinoma into two subtypes: Cluster 1, most of which are young patients and display more immune and stromal cell components in tumor microenvironment and lower tumor priority; and Cluster 2, which show early stages and better PFS. Moreover, by using a three-phase training, test and validation process, we construct a 6-gene signature that can classify the prognostic risk of patients, and which present higher robustness and clinical usability compared with three previous reported prognostic gene signatures.
Publish Date 2022-02-10 14:26
Citation Chang J, Wang X, Zhang W, Tan C, Sheng W, Xu M. Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes. World J Gastrointest Oncol 2022; 14(2): 478-497
URL https://www.wjgnet.com/1948-5204/full/v14/i2/478.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i2.478
Full Article (PDF) WJGO-14-478.pdf
Full Article (Word) WJGO-14-478.docx
Manuscript File 70492_Auto_Edited-LLW-Filipodia.docx
Answering Reviewers 70492-Answering reviewers.pdf
Audio Core Tip 70492-Audio core tip.m4a
Biostatistics Review Certificate 70492-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 70492-Conflict-of-interest statement.pdf
Copyright License Agreement 70492-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 70492-Grant application form(s).pdf
Institutional Animal Care and Use Committee Approval Form or Document 70492-Institutional animal care and use committee statement.pdf
Institutional Review Board Approval Form or Document 70492-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 70492-Language certificate.pdf
Supplementary Material 70492-Supplementary material.pdf
Peer-review Report 70492-Peer-review(s).pdf
Scientific Misconduct Check 70492-Bing-Wang LL-2.png
Scientific Editor Work List 70492-Scientific editor work list.pdf